Glenmede Trust’s Aceragen Inc ACGN Stock Holding History

Glenmede Trust’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16	Closed	-$3K	–	2697
2016 Q2	$3K	Hold	16	–	–	﹤0.01%	2346
2016 Q1	$4K	Hold	16	–	–	﹤0.01%	2285
2015 Q4	$6K	Hold	16	–	–	﹤0.01%	2224
2015 Q3	$7K	Buy	+16	New	+$7.08K	﹤0.01%	2211

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glenmede Trust's ACGN Position: Q3 2016 in Review

Glenmede Trust sold out of Aceragen Inc (ACGN) in Q3 2016, closing a stake of 16 shares — an estimated $3K sold.

Glenmede Trust first reported a position in ACGN in Q3 2015 and held it in 4 quarters. The position peaked at $7K in Q3 2015. 78 funds tracked by Wall St. Rank hold ACGN as of Q3 2016.

Glenmede Trust reported no remaining Aceragen Inc position as of Q3 2016 after selling out during the quarter.
Glenmede Trust sold 16 Aceragen Inc shares in Q3 2016, an estimated $3K.
Glenmede Trust first reported a position in Aceragen Inc in Q3 2015 and held it in 4 quarters.
Glenmede Trust's Aceragen Inc position peaked at $7K in Q3 2015.
78 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2016.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.